MA38838A1 - Piperidinylindole derivatives and their use as complement factor b inhibitors - Google Patents

Piperidinylindole derivatives and their use as complement factor b inhibitors

Info

Publication number
MA38838A1
MA38838A1 MA38838A MA38838A MA38838A1 MA 38838 A1 MA38838 A1 MA 38838A1 MA 38838 A MA38838 A MA 38838A MA 38838 A MA38838 A MA 38838A MA 38838 A1 MA38838 A1 MA 38838A1
Authority
MA
Morocco
Prior art keywords
inhibitors
piperidinylindole
derivatives
complement factor
factor
Prior art date
Application number
MA38838A
Other languages
French (fr)
Other versions
MA38838B1 (en
Inventor
Takeru Ehara
Rajeshri Ganesh Karki
Chun Zhang
Christopher Adams
Michael Paul Capparelli
Nello Mainolfi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2014/046515 external-priority patent/WO2015009616A1/en
Publication of MA38838A1 publication Critical patent/MA38838A1/en
Publication of MA38838B1 publication Critical patent/MA38838B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne un composé de formule i : (i), un procédé de production des composés selon l'invention, et leurs utilisations thérapeutiques en tant qu'inhibiteurs de la voie alternative du complément, en particulier, du facteur b. Une combinaison d'agents pharmaceutiquement actifs et une composition pharmaceutique sont en outre décrites.This invention relates to a compound of formula I: (i), a process for producing the compounds of the invention, and their therapeutic uses as inhibitors of the alternative complement pathway, in particular, factor b. A combination of pharmaceutically active agents and a pharmaceutical composition are further described.

MA38838A 2013-07-15 2014-07-14 Piperidinylindole derivatives and their use as complement factor b inhibitors MA38838B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361846355P 2013-07-15 2013-07-15
PCT/US2014/046515 WO2015009616A1 (en) 2013-07-15 2014-07-14 Piperidinyl indole derivatives and their use as complement factor b inhibitors

Publications (2)

Publication Number Publication Date
MA38838A1 true MA38838A1 (en) 2017-03-31
MA38838B1 MA38838B1 (en) 2017-11-30

Family

ID=56125325

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38838A MA38838B1 (en) 2013-07-15 2014-07-14 Piperidinylindole derivatives and their use as complement factor b inhibitors

Country Status (2)

Country Link
AR (1) AR096904A1 (en)
MA (1) MA38838B1 (en)

Also Published As

Publication number Publication date
MA38838B1 (en) 2017-11-30
AR096904A1 (en) 2016-02-03

Similar Documents

Publication Publication Date Title
MA37477A1 (en) Modulators of complement pathways and their uses
MA34837B1 (en) INDOLIC COMPOUNDS OR ANALOGS THEREFOR USEFUL IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
CY1124882T1 (en) 1,4-DI-CONSTITUTED PYRIDAZINE ANALOGUES AND METHODS FOR THERAPEUTIC TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
MA42678B1 (en) NEW SUBSTITUTED NUCLEOSIDE ANALOGS WITH BICYCLIC AROMATIC CYCLE 6-6 FOR USE AS PRMT5 INHIBITORS
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
MA35275B1 (en) Compounds of tetrahydropyridopyridine and tetrahydropyridopyrimidine and their use as c5a receptor modulators
MA35032B1 (en) GLYCOSIDE DERIVATIVES AND THEIR USES IN THE TREATMENT OF DIABETES
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
MA38330B1 (en) Butanoic phosphonic acid derivatives of bisphenol substituted as nep inhibitors (neutral endopeptidase)
EA201492023A1 (en) REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION
EA201690153A1 (en) SUBSTITUTED PETROPHORANE AND BENZOXAZOLYL COMPOUNDS AND THEIR APPLICATIONS
EA201590200A1 (en) MODULATORS OF THE COMPLEMENT ACTIVATION WAY AND THEIR APPLICATION
EA201490724A1 (en) SUBSTITUTED COMPOUNDS OF TETRAHYDROISOCHINOLINE AS INHIBITORS OF XIA
MA33358B1 (en) Arylperidine as aldosterone synthase inhibitors
MX2016000675A (en) Aminomethyl-biaryl derivatives as complement factor d inhibitors and uses thereof.
EA201592255A1 (en) DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE
MA39983A (en) CARBOXAMIDE DERIVATIVES
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MA38076A1 (en) Oxazolidin-2-one-pyrimidine derivatives
MA38679B1 (en) Cxcr7 receiver modulators
EA201792594A1 (en) POSITIVE ALLOSTERIC MODULATORS OF MUSARIN M1 RECEPTOR
EA201890684A1 (en) FLUORINDOL DERIVATIVES AS A POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE M1 RECEPTOR
MA38838B1 (en) Piperidinylindole derivatives and their use as complement factor b inhibitors
MA37879B1 (en) Stabilized amorphous form of agomelatine, process for its preparation and pharmaceutical compositions containing it